Drug Shortage Report for TESTOSTERONE ENANTHATE INJECTION, USP
Report ID | 249532 |
Drug Identification Number | 02536315 |
Brand name | TESTOSTERONE ENANTHATE INJECTION, USP |
Common or Proper name | TESTOSTERONE ENANTHATE INJECTION, USP |
Company Name | HIKMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | TESTOSTERONE ENANTHATE |
Strength(s) | 200MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR |
Packaging size | 5mL |
ATC code | G03BA |
ATC description | ANDROGENS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2025-02-04 |
Actual start date | |
Estimated end date | 2025-03-21 |
Actual end date | 2025-03-24 |
Shortage status | Resolved |
Updated date | 2025-03-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2025-02-04 | English | Compare |
v2 | 2025-02-04 | French | Compare |
v3 | 2025-02-05 | English | Compare |
v4 | 2025-03-03 | English | Compare |
v5 | 2025-03-03 | French | Compare |
v6 | 2025-03-17 | English | Compare |
v7 | 2025-03-17 | English | Compare |
v8 | 2025-03-17 | French | Compare |
v9 | 2025-03-24 | English | Compare |
v10 | 2025-03-24 | French | Compare |
v11 | 2025-03-25 | English | Compare |
Showing 1 to 11 of 11